Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures

PUBLICATION: Ann Surg Oncol (2016) 23: 3317. https://doi.org/10.1245/s10434-016-5329-6. AUTHORS: Peter Read More

2024-03-25T09:19:31-04:00July 6th, 2016|BluePrint, Evidence, NBRST, Neoadjuvant|

Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy

PUBLICATION: Ann Surg Oncol (2016) 23: 1522. https://doi.org/10.1245/s10434-015-5030-1. AUTHORS: Paul Read More

2024-03-25T09:21:21-04:00May 1st, 2016|BluePrint, Evidence, NBRST, Neoadjuvant|

Molecular Subtyping Improves Diagnostic Stratification of Patients with Primary Breast Cancer into Prognostically-Defined Risk Groups

PUBLICATION: Breast Cancer Res Treat (2015) 154: 81. https://doi.org/10.1007/s10549-015-3587-9. AUTHORS: Read More

2024-03-25T09:23:03-04:00November 1st, 2015|BluePrint, Evidence, Other|

Molecular Subtyping Predicts Pathologic Tumor Response in Early-Stage Breast Cancer Treated with Neoadjuvant Docetaxel Plus Capecitabine with or without Trastuzumab Chemotherapy

PUBLICATION: Med Oncol. (2014) 31: 163. https://doi.org/10.1007/s12032-014-0163-9. AUTHORS: Soley Bayraktar, Read More

2024-03-25T10:18:35-04:00September 4th, 2014|BluePrint, Evidence, Neoadjuvant|

Estrogen Receptor Splice Variants as a Potential Source of False-Positive Estrogen Receptor Status in Breast Cancer Diagnostics

PUBLICATION: Breast Cancer Res Treat (2013) 140:475โ€“484 DOI 10.1007/s10549-013-2648-1 AUTHORS: Read More

2024-03-25T10:44:00-04:00August 4th, 2013|Adjuvant, BluePrint, Evidence|

Molecular Subtyping of Early-Stage Breast Cancer Identifies a Group of Patients Who Do Not Benefit from Neoadjuvant Chemotherapy

PUBLICATION:ย  Breast Cancer Res Treat. 2013 Jun;139(3):759-67. doi: 10.1007/s10549-013-2572-4. AUTHORS:ย  Read More

2024-03-25T10:46:58-04:00June 12th, 2013|BluePrint, Evidence, Neoadjuvant|

Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients

PUBLICATION: Ann Surg Oncol. 2012 Oct;19(10):3257-63. doi: 10.1245/s10434-012-2561-6. Epub 2012 Read More

2024-03-25T10:51:59-04:00August 15th, 2012|BluePrint, Evidence, Other, Validation|

A Diagnostic Gene Profile for Molecular Subtyping of Breast Cancer Associated with Treatment Response

PUBLICATION: Breast Cancer Res Treat (2012) 133: 37. https://doi.org/10.1007/s10549-011-1683-z. AUTHORS: Read More

2024-03-25T10:54:08-04:00May 1st, 2012|BluePrint, Evidence, Neoadjuvant|
Go to Top